Yusuf Hared Abdi, Sharmake Gaiye Bashir, Zakaria Ibrahim Issack
{"title":"Strengthening One Health AMR Surveillance in Africa: From Cross-Sectoral Data to Policy Action.","authors":"Yusuf Hared Abdi, Sharmake Gaiye Bashir, Zakaria Ibrahim Issack","doi":"10.2147/IDR.S640711","DOIUrl":null,"url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) has emerged as one of the greatest threats to global health, with Africa bearing a disproportionate burden: an estimated 1.05 million deaths were associated with bacterial AMR and approximately 250,000 deaths were directly attributable to AMR in the WHO African Region in 2019 alone. This burden reflects high infectious disease prevalence, limited diagnostic capacity, weak antimicrobial stewardship, and fragmented surveillance systems. Given that resistant pathogens and resistance genes circulate across humans, animals, and the environment, effective surveillance requires a coordinated One Health approach. This narrative review synthesizes published literature (2015-2026) identified through PubMed, Scopus, Web of Science, and Google Scholar to assess the status of One Health AMR surveillance in Africa, examine progress across the human, animal, and environmental sectors, identify major implementation barriers, and propose strategic priorities for strengthening integrated surveillance systems. The evidence reviewed shows that participation in surveillance initiatives such as GLASS has expanded and laboratory capacity has improved in several countries; however, substantial gaps remain in veterinary and environmental surveillance, laboratory infrastructure, data interoperability, governance, workforce capacity, and sustainable financing. Fragmented information systems and limited cross-sectoral collaboration continue to impede timely detection of emerging resistance and evidence-informed policy action. Based on these findings, we recommend prioritizing integrated governance structures, strengthened laboratory networks, interoperable digital surveillance platforms, and sustainable domestic financing as foundational steps, with genomic technologies, wastewater surveillance, and regional collaboration serving as complementary priorities as feasibility and resources allow. Strengthening One Health surveillance will be critical for improving early detection of resistant pathogens, informing antimicrobial stewardship, supporting outbreak preparedness, and reducing the growing health and economic burden of AMR across Africa.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"19 ","pages":"640711"},"PeriodicalIF":3.2000,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592423/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S640711","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Antimicrobial resistance (AMR) has emerged as one of the greatest threats to global health, with Africa bearing a disproportionate burden: an estimated 1.05 million deaths were associated with bacterial AMR and approximately 250,000 deaths were directly attributable to AMR in the WHO African Region in 2019 alone. This burden reflects high infectious disease prevalence, limited diagnostic capacity, weak antimicrobial stewardship, and fragmented surveillance systems. Given that resistant pathogens and resistance genes circulate across humans, animals, and the environment, effective surveillance requires a coordinated One Health approach. This narrative review synthesizes published literature (2015-2026) identified through PubMed, Scopus, Web of Science, and Google Scholar to assess the status of One Health AMR surveillance in Africa, examine progress across the human, animal, and environmental sectors, identify major implementation barriers, and propose strategic priorities for strengthening integrated surveillance systems. The evidence reviewed shows that participation in surveillance initiatives such as GLASS has expanded and laboratory capacity has improved in several countries; however, substantial gaps remain in veterinary and environmental surveillance, laboratory infrastructure, data interoperability, governance, workforce capacity, and sustainable financing. Fragmented information systems and limited cross-sectoral collaboration continue to impede timely detection of emerging resistance and evidence-informed policy action. Based on these findings, we recommend prioritizing integrated governance structures, strengthened laboratory networks, interoperable digital surveillance platforms, and sustainable domestic financing as foundational steps, with genomic technologies, wastewater surveillance, and regional collaboration serving as complementary priorities as feasibility and resources allow. Strengthening One Health surveillance will be critical for improving early detection of resistant pathogens, informing antimicrobial stewardship, supporting outbreak preparedness, and reducing the growing health and economic burden of AMR across Africa.
抗菌素耐药性已成为全球健康面临的最大威胁之一,非洲承受着不成比例的负担:仅2019年,世卫组织非洲区域估计就有105万例死亡与细菌性抗菌素耐药性有关,约25万例死亡直接与抗菌素耐药性有关。这一负担反映了传染病的高流行率、有限的诊断能力、薄弱的抗微生物药物管理和分散的监测系统。鉴于耐药病原体和耐药基因在人类、动物和环境中传播,有效的监测需要协调一致的“同一个健康”方法。本叙述性综述综合了通过PubMed、Scopus、Web of Science和谷歌Scholar确定的已发表文献(2015-2026),以评估非洲“一种健康”抗菌药耐药性监测的现状,检查人类、动物和环境部门的进展,确定主要实施障碍,并提出加强综合监测系统的战略重点。审查的证据表明,在一些国家,对监测行动(如GLASS)的参与有所扩大,实验室能力有所提高;然而,在兽医和环境监测、实验室基础设施、数据互操作性、治理、劳动力能力和可持续融资方面仍存在巨大差距。支离破碎的信息系统和有限的跨部门合作继续阻碍及时发现新出现的耐药性和根据证据采取政策行动。基于这些发现,我们建议优先考虑将综合治理结构、加强实验室网络、可互操作的数字监测平台和可持续的国内融资作为基础步骤,并在可行性和资源允许的情况下,将基因组技术、废水监测和区域合作作为补充重点。加强“同一个健康”监测对于改善耐药病原体的早期发现、为抗菌素管理提供信息、支持疫情防范以及减轻非洲各地抗菌素耐药性日益严重的健康和经济负担至关重要。
期刊介绍:
About Journal
Editors
Peer Reviewers
Articles
Article Publishing Charges
Aims and Scope
Call For Papers
ISSN: 1178-6973
Editor-in-Chief: Professor Suresh Antony
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.